Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
How to further solidify data on systemic therapy in metastatic renal cell carcinoma (mRCC) in German mRCC registry on the treatment reality.

Goebell, P., Müller, L., Blumenstengel, K., Hübner, A., Lück, A., Koska, M., Marschner, N., 2012.

Eur Urol Suppl 2012;11,e79a DOI:10.1016/S1569-9056(12)60078-5

Abstract

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: EAU / Journal: -
TNK
2012
Treatment of younger and elderly colorectal cancer patients in German outpatient centres – data from the clinical TKK registry.

Freier, W., Groschek, M., Schröder, J., von Verschuer, U., Jänicke, M., Marschner, N., 2012.

Onkologie 35 (suppl 6)(P193), 56. doi:10.1159/000170919

Abstract

Download

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TKK
2012
Compliance, analgesic use and side-effect protection within a German cohort of the TEAM trial.

Bossart, M., Becker, M., Hadji, P., Kieback, D.G., Hasenburg, A., 2012.

Anticancer Res 32, 3933–3938.

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Anticancer Research
TEAM
2012
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study.

Bartlett, J.M.S., Bloom, K.J., Piper, T., Lawton, T.J., van de Velde, C.J.H., Ross, D.T., Ring, B.Z., Seitz, R.S., Beck, R.A., Hasenburg, A., Kieback, D., Putter, H., Markopoulos, C., Dirix, L., Seynaeve, C., Rea, D., 2012.

J Clin Oncol 30, 4477–4484. doi:10.1200/JCO.2012.42.8896

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Journal of Clinical Oncology
TEAM
2012
Reduced HFSR incidence observed in a randomized phase II study in advanced breast cancer patients treated with sorafenib and paclitaxel by initial ramp-up dose escalation (PASO).

Overkamp, F., Steffens, C., Abenhardt, W., Lerchenmüller, C., Nusch, A., Göhler, T., Groschek, M., Hegewisch-Becker, S., Marschner, N., Rösel, S., Salat, C., Decker, T., 2011.

J Cancer Res Clin Oncol 138(Suppl.1)(0026), 62. doi:10.1007/s00432-011-1144-4

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DKK / Journal: Journal of Cancer Research and Clinical Oncology
PASO
2011
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.

van de Velde, C.J.., Rea, D., Seynaeve, C., Putter, H., Hasenburg, A., Vannetzel, J.M., Paridaens, R., Markopoulos, C., Hozumi, Y., Hille, E., others, 2011.

Lancet 377, 321–331. doi:10.1016/S0140-6736(10)62312-4

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: The Lancet
TEAM
2011
REASON: TKI sensitive EGFR mutation status and associated characteristics of advanced NSCLC patients – Results from a German registry.

Thomas, M., Eberhardt, W., Graf von der Schluenburg, J., Dietel, M., Schirmacher, P., Gutendirf, B., Schaller, F., Schütte, W., 2011.

Onkologie 34 (suppl 6)(V451), 124.

Abstract

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGHO / Journal: Onkologie
REASON
2011
EGFR Mutation Status in NSCLC Patients Stage IIIB/IV in Germany – Initial Results from a German Registry.

Thomas, M., Eberhardt, W., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Gutendorf, B., Zirrgiebel, U., Schütte, W., 2011.

EMCC / ESMO, European Multidisciplinary Cancer Congress, Stockholm (Abstract 9015), 596.

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: EMCC (ESMO) / Journal: -
REASON
2011
The treatment of lung cancer in German outpatient centres. Data from a clinical registry – TLK Registry.

Tessen, H.W., Hutzschenreuter, U., Steffens, C.C., Nusch, A., Spirik, J., Marschner, N., 2011.

Onkologie 34 (suppl 6)(P533), 153. doi:10.1159/000333301

Abstract

Download

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TLK
2011
Intention of Treating Chemotherapy-Induced Neutropenia with Biosimilar Filgrastim and Change of Practice.

Tesch, H., Turner, M., Indorf, M., 2011.

SIOG Annual Meeting, Paris.

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: SIOG / Journal: -
HEXAFIL
2011